Literature DB >> 25609620

NLP-12 engages different UNC-13 proteins to potentiate tonic and evoked release.

Zhitao Hu1, Amy B Vashlishan-Murray2, Joshua M Kaplan3.   

Abstract

A neuropeptide (NLP-12) and its receptor (CKR-2) potentiate tonic and evoked ACh release at Caenorhabditis elegans neuromuscular junctions. Increased evoked release is mediated by a presynaptic pathway (egl-30 Gαq and egl-8 PLCβ) that produces DAG, and by DAG binding to short and long UNC-13 proteins. Potentiation of tonic ACh release persists in mutants deficient for egl-30 Gαq and egl-8 PLCβ and requires DAG binding to UNC-13L (but not UNC-13S). Thus, NLP-12 adjusts tonic and evoked release by distinct mechanisms.
Copyright © 2015 the authors 0270-6474/15/351038-05$15.00/0.

Entities:  

Keywords:  C. elegans; CCK; Munc13; NLP-12; UNC-13; neuropeptide

Mesh:

Substances:

Year:  2015        PMID: 25609620      PMCID: PMC4300317          DOI: 10.1523/JNEUROSCI.2825-14.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  44 in total

1.  One GABA and two acetylcholine receptors function at the C. elegans neuromuscular junction.

Authors:  J E Richmond; E M Jorgensen
Journal:  Nat Neurosci       Date:  1999-09       Impact factor: 24.884

2.  Cholecystokinin (CCK-8) modulates vesicular release of excitatory amino acids in rat hippocampal nerve endings.

Authors:  A I Breukel; F H Lopes da Silva; W E Ghijsen
Journal:  Neurosci Lett       Date:  1997-09-26       Impact factor: 3.046

3.  Munc13-1 is a presynaptic phorbol ester receptor that enhances neurotransmitter release.

Authors:  A Betz; U Ashery; M Rickmann; I Augustin; E Neher; T C Südhof; J Rettig; N Brose
Journal:  Neuron       Date:  1998-07       Impact factor: 17.173

4.  Genetic analysis of synaptotagmin 2 in spontaneous and Ca2+-triggered neurotransmitter release.

Authors:  Zhiping P Pang; Jianyuan Sun; Josep Rizo; Anton Maximov; Thomas C Südhof
Journal:  EMBO J       Date:  2006-04-27       Impact factor: 11.598

5.  UNC-13 and UNC-10/rim localize synaptic vesicles to specific membrane domains.

Authors:  Robby M Weimer; Elena O Gracheva; Olivier Meyrignac; Kenneth G Miller; Janet E Richmond; Jean-Louis Bessereau
Journal:  J Neurosci       Date:  2006-08-02       Impact factor: 6.167

6.  Antagonistic regulation of synaptic vesicle priming by Tomosyn and UNC-13.

Authors:  Jason M McEwen; Jon M Madison; Michael Dybbs; Joshua M Kaplan
Journal:  Neuron       Date:  2006-08-03       Impact factor: 17.173

7.  Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion.

Authors:  Jayeeta Basu; Andrea Betz; Nils Brose; Christian Rosenmund
Journal:  J Neurosci       Date:  2007-01-31       Impact factor: 6.167

8.  Presynaptic ryanodine receptors are required for normal quantal size at the Caenorhabditis elegans neuromuscular junction.

Authors:  Qiang Liu; Bojun Chen; Maya Yankova; D Kent Morest; Ed Maryon; Arthur R Hand; Michael L Nonet; Zhao-Wen Wang
Journal:  J Neurosci       Date:  2005-07-20       Impact factor: 6.167

9.  Structural basis for a Munc13-1 homodimer to Munc13-1/RIM heterodimer switch.

Authors:  Jun Lu; Mischa Machius; Irina Dulubova; Han Dai; Thomas C Südhof; Diana R Tomchick; Josep Rizo
Journal:  PLoS Biol       Date:  2006-07       Impact factor: 8.029

10.  Tomosyn inhibits synaptic vesicle priming in Caenorhabditis elegans.

Authors:  Elena O Gracheva; Anna O Burdina; Andrea M Holgado; Martine Berthelot-Grosjean; Brian D Ackley; Gayla Hadwiger; Michael L Nonet; Robby M Weimer; Janet E Richmond
Journal:  PLoS Biol       Date:  2006-07       Impact factor: 8.029

View more
  9 in total

1.  Retrograde Synaptic Inhibition Is Mediated by α-Neurexin Binding to the α2δ Subunits of N-Type Calcium Channels.

Authors:  Xia-Jing Tong; Eduardo Javier López-Soto; Lei Li; Haowen Liu; Daniel Nedelcu; Diane Lipscombe; Zhitao Hu; Joshua M Kaplan
Journal:  Neuron       Date:  2017-06-29       Impact factor: 17.173

Review 2.  Neurotransmitter signaling through heterotrimeric G proteins: insights from studies in C. elegans.

Authors:  Michael R Koelle
Journal:  WormBook       Date:  2018-12-11

3.  Gut neuroendocrine signaling regulates synaptic assembly in C. elegans.

Authors:  Yanjun Shi; Lu Qin; Mengting Wu; Junyu Zheng; Tao Xie; Zhiyong Shao
Journal:  EMBO Rep       Date:  2022-06-24       Impact factor: 9.071

4.  A conserved neuropeptide system links head and body motor circuits to enable adaptive behavior.

Authors:  Shankar Ramachandran; Navonil Banerjee; Raja Bhattacharya; Michele L Lemons; Jeremy Florman; Christopher M Lambert; Denis Touroutine; Kellianne Alexander; Liliane Schoofs; Mark J Alkema; Isabel Beets; Michael M Francis
Journal:  Elife       Date:  2021-11-12       Impact factor: 8.713

5.  Modulation of Gq-Rho Signaling by the ERK MAPK Pathway Controls Locomotion in Caenorhabditis elegans.

Authors:  Brantley Coleman; Irini Topalidou; Michael Ailion
Journal:  Genetics       Date:  2018-04-03       Impact factor: 4.562

6.  Sentryn and SAD Kinase Link the Guided Transport and Capture of Dense Core Vesicles in Caenorhabditis elegans.

Authors:  Logan M Morrison; Stacey L Edwards; Laura Manning; Natalia Stec; Janet E Richmond; Kenneth G Miller
Journal:  Genetics       Date:  2018-11       Impact factor: 4.562

7.  The M domain in UNC-13 regulates the probability of neurotransmitter release.

Authors:  Haowen Liu; Lei Li; Seema Sheoran; Yi Yu; Janet E Richmond; Jingyao Xia; Jing Tang; Jie Liu; Zhitao Hu
Journal:  Cell Rep       Date:  2021-03-09       Impact factor: 9.423

Review 8.  (M)Unc13s in Active Zone Diversity: A Drosophila Perspective.

Authors:  Chengji Piao; Stephan J Sigrist
Journal:  Front Synaptic Neurosci       Date:  2022-01-03

9.  Regulation of two motor patterns enables the gradual adjustment of locomotion strategy in Caenorhabditis elegans.

Authors:  Ingrid Hums; Julia Riedl; Fanny Mende; Saul Kato; Harris S Kaplan; Richard Latham; Michael Sonntag; Lisa Traunmüller; Manuel Zimmer
Journal:  Elife       Date:  2016-05-25       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.